Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

Clinical trial NCT00971334 · COMPLETED

Trial details

NCT number: NCT00971334
Sponsor: Sequenom, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Pregnancy Aneuploidy Down Syndrome Edwards Syndrome

Start date: 2009-08-01
Primary completion: 2011-09-01
Enrollment: 2502

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.